The lifetime risk of developing ovarian and/or fallopian tube cancer (referred to as ovarian cancer hereafter) has been estimated to be between 44 to 49% for women with a BRCA1 mutation and between 17 to 21% for those with a BRCA2 mutation [6, 7]. The gene discussed is BRCA1; the disease is ovarian cancer.